Metraipolis › archive › dc_a17dfb35595c

Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study — Europe PMC PMID:40969675

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40969675
DOI
10.1016/j.omtm.2025.101568
License (as archived)
solo-consultazione
Archived
2026-11-10T13:36:37.791Z
SHA-256 of the archived text
fbb66066aa54f0a16dccd33435f9fcfe5085ea56205dee9605bfd1a21546dca5
Stable URL of this page
https://metraipolis.com/documento/dc_a17dfb35595c

How to cite

Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study — Europe PMC PMID:40969675 — Europe PMC (en), https://europepmc.org/article/MED/40969675 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a17dfb35595c (Metraipolis archive dc_a17dfb35595c, sha256 fbb66066aa54f0a16dccd33435f9fcfe5085ea56205dee9605bfd1a21546dca5)
BibTeX
@misc{dca17dfb35595c,
  title = {Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study — Europe PMC PMID:40969675},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40969675},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a17dfb35595c; sha256 fbb66066aa54f0a16dccd33435f9fcfe5085ea56205dee9605bfd1a21546dca5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40969675. Agents can read the archived copy with the MCP tool read_document.